News Release Monday, March 3, 2025 High rate of oral immunotherapy side effects in NIH…
Continue ReadingTag: Omalizumab

Omalizumab outperforms oral immunotherapy in treating multi-food allergy
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more…
Continue Reading